Announcement

PHILADELPHIA — Disrupting sleep-wake cycles from a predominantly daytime to a delayed eating lifestyle, --  i.e., skipping breakfast and making lunch the first meal of the day, plus eating late dinner, disrupts the body’s natural circadian (24-hour) rhythm, the cycle that tells us when to sleep, wake up, eat, and influences hormones and other functions. Penn research has previously shown that delayed eating increases weight, negatively affects fat metabolism, and increases glucose, insulin, triglyceride and cholesterol levels – markers implicated in obesity, heart disease, diabetes and other health problems. Now these researchers have received a grant to figure out why.

Namni Goel, PhD, a research associate professor of psychology in Sleep and Chronobiology, and Kelly Allison, PhD, an associate professor of psychology in Psychiatry, in the Perelman School of Medicine at the University of Pennsylvania, have received a 5-year, $3.75 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to continue their research investigating how meal times influence human health.

In their initial research, the team found a daytime eating schedule, compared to a delayed eating schedule, promoted weight loss and a positive profile for fuel oxidation, energy metabolism and hormonal markers in adults of normal weight. This work also showed that short sleep duration increased caloric intake, particularly late at night, leading to weight gain and impaired metabolism. The current study will keep sleep timing and duration constant, only varying the timing of eating, to determine its independent effect on weight and other metabolic measures.

A Centers for Disease Control and Prevention (CDC) report released this month found that 39.8 percent of US adults were obese in 2015-2016. Additionally, the CDC reports that 610,000 people in the United States – one in every four deaths – die of heart disease each year.

“We know from previous research, that the time of day you eat your meals has a significant effect on the body’s weight regulation and other health markers,” said Allison, who also directs the Center for Weight and Eating Disorders. “Now we’re delving deeper into the underlying mechanisms that explain these effects, and how they influence specific populations.”

The five-year NIDDK grant allows the team to conduct a randomized, long-term study of subjects’ eating times to compare weight and metabolic effects and circadian-mediated mechanisms of a daytime versus delayed eating schedule, each of 8 weeks duration, in adults with obesity (BMI of 30-50 kg/m2) without metabolic syndrome (characterized by high blood sugar, high blood pressure, excessive body fat around the waist, and abnormal triglyceride or cholesterol levels). The sleep-wake cycle (hours of the day spent sleeping) and activity levels will be controlled.

“By targeting these mechanisms, we can help in developing treatment of a range of conditions plaguing societies across the globe,” said Goel. “This research has potentially broad clinical implications, including informing recommendations of healthy timed eating habits that influence weight and metabolic health, identifying targets for medical interventions for obesity, and preventing metabolic syndrome and diabetes from developing in persons with obesity.”

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.

Share This Page: